An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO with Open-Label Safety Period in Pediatric Subjects with Epilepsy
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Neuroscience Research -
Principal Investigator
-
Sponsor
Neureils
This is a research study to evaluate the pharmacokinetics (PK), safety and tolerability after a single intranasal dose of VALTOCO (diazepam nasal spray), followed by a long-term safety period, where VALTOCO will be used “as needed”, in 2–5-year-old subjects